bendamustinefludarabine/cyclophosphamidevenetoclaxtocilizumabCD4CARIndiana UniversityFDAAMLacute myeloid leukemiaschronic myelomonocytic leukemia+2 more
…eived conditioning with either fludarabine/cyclophosphamide, or bendamustine, followed by CD4CAR in a 3+3 dose-escalation design. Safety and…